The vigorous involvement of health-system pharmacists is critical in reducing surgery-related infections under guidelines recently promulgated by Medicare's National Surgical Infection Prevention Project (SIP) (see Drug Topics, July 26). So declared Charles E. Stimler, M.D., medical officer with IPRO, a Medicare quality improvement organization (QIO) in Lake Success, N.Y.